Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary

Published:2013-11 Issue:21-22 Volume:18 Page:1052-1066
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Jarzabek Monika A.,Sweeney Kieron J.,Evans Rhys L.,Jacobs Andreas H.,Stupp Roger,O’Brien Donncha,Berger Mitchel S.,Prehn Jochen H.M.,Byrne Annette T.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference104 articles.

1. National Cancer Institute at the National Institutes of Heath. Available at: http://www.cancer.gov/, accessed June 2013.

2. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol.,2007

3. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009

4. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

5. Advanced MRI in the management of adult gliomas;Jenkinson;Br. J. Neurosurg.,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OBSERVE: guidelines for the refinement of rodent cancer models;Nature Protocols;2024-07-11

2. Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway;Cancer Chemotherapy and Pharmacology;2022-01-08

3. DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance;Genetics and Molecular Biology;2020

4. [18F]FET PET is a useful tool for treatment evaluation and prognosis prediction of anti-angiogenic drug in an orthotopic glioblastoma mouse model;Laboratory Animal Research;2018

5. Radioiodine-labeled anti-epidermal growth factor receptor binding bovine serum albumin-polycaprolactone for targeting imaging of glioblastoma;Oncology Reports;2017-09-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3